[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368518-105":59,"doc-detail-368518-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","polymer-nanoparticles-advancements-for-gynecological-cancers","Polymer Nanoparticles Advancements for Gynecological Cancers","","Gynecological cancers are a leading cause of death in women and remain a major global health challenge. Surgical and chemotherapy approaches are still first-line, yet high morbidity, mortality, recurrence, and resistance drive the search for advanced theranostic strategies. This review summarizes polymer nanoparticles for tumor diagnosis and treatment, emphasizing drug delivery, imaging, combination therapy, and theranostic integration, along with polymer/cargo composition, principles, characteristics, and clinical translation challenges.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/polymer-nanoparticles-advancements-for-gynecological-cancers/368518/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/polymer-nanoparticles-advancements-for-gynecological-cancers/368518.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are polymer nanoparticles increasingly important for gynecological cancer research?","Question",{"text":112,"@type":113},"They offer superior targeting ability and delivery efficiency, supporting both diagnosis and treatment. Their drug-loading flexibility and biocompatibility also make them promising therapeutic carriers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What topics does the review cover about polymer nanoparticles in gynecological cancers?",{"text":117,"@type":113},"It covers polymer nanoparticle roles in tumor diagnosis and treatment, including drug delivery, imaging, combination therapy, and theranostic integration. It also summarizes polymer composition, principles, characteristics, and diverse therapeutic applications such as chemotherapy and immunotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges remain before polymer nanoparticles can be widely used clinically?",{"text":121,"@type":113},"Clinical translation is limited by biosafety, heterogeneity of clinical effects, targeted delivery efficiency, and scale-up production. Very few nanoparticle systems have succeeded in moving into routine practice.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368518,1790472739,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nPolymer Nanoparticles Advancements for Gynecological Cancers  \nXiaorui Lin  1 , 2 , Zihan Li 1 , 2 , Yibao Huang 1 , 2 , Yinuo Li 1 , 2 , Yuting Li 1 , 2 , Ling Zhang  1 , 2 , Mingfu Wu 1 , 2  \n1National Clinical Research Center for Obstetrical and Gynecological Diseases, Department of Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People’s Republic of China; 2Key Laboratory of Cancer Invasion and Metastasis, Ministry of Education, Wuhan 430030, People’s Republic of China  \nCorrespondence: Mingfu Wu, [Email mingfuwutj@163.com](Email mingfuwutj@163.com)  \n\n| Abstract: Gynecological cancers represent one of the leading causes of death in women and pose a critical global health challenge. While surgery and chemotherapy remain the first-line therapies for gynecological cancers, the persistently high morbidity and mortality rates have driven the urgent exploration of novel theranostic strategies. In recent years, polymer nanoparticles (PNPs) have gained increasing attention in the diagnosis and treatment of cancer due to their superior targeting ability and delivery efficiency. This review provides an overview of PNPs and their role in tumor diagnosis and treatment, with a strategic focus on their utility in gynecological cancers. It covers drug delivery, imaging, combination therapy, and theranostic integration in gynecological cancers, and summarizes the composition, principles and characteristics of diverse polymers and their cargoes. Furthermore, this work highlights innovative applications of PNPs in gynecological cancers management, spanning chemotherapy, immunotherapy, PARPi therapy, phototherapy and other therapies. Despite promising preclinical advancements in PNPs, formidable challenges persist in their clinical translation. This review serves as a comprehensive resource for researchers and clinicians aiming to optimize gynecological cancers theranostics as well as accelerate the development and clinical translation of PNPs.\u003Cbr>Keywords: polymer nanoparticles, gynecological cancer, theranostics, nanoparticles, ovarian cancer, cervical cancer, endometrial cancer, nanomedicine |\n| --- |\n| Introduction\u003Cbr>Nanoparticles (NPs) are solid colloidal particles, usually between 10–1000 nm in size, 1 which can be composed of lipids, metals, metal oxides, polymers and other materials.2 Polymer nanoparticles (PNPs) is a collective term for nano-sized particles made of polymer,3 with the optimal size of 10–200 nm for their in vivo application.4 PNPs have superior biocompatibility and drug-loading flexibility compared to other NPs. PNPs are mainly prepared by self-assembly, nanoprecipitation, dialysis, solvent evaporation, salting-out, based on preformed polymers or on monomers.1,3–5 The circulation time of PNPs in vivo is determined by their physicochemical properties, while their controllable shape, size, and surface modifications allow them to be a promising therapeutic carrier.4 PNPs can encapsulate various cargoes to improve their solubility, bioavailability, biocompatibility, half-life, etc.6 Then they deliver and release the cargoes precisely to exert therapeutic or diagnostic effects. Therefore, PNPs have undergone extensive research in the treatment and prevention of tumors,7–9 cardiovascular diseases 10, 11, and infectious diseases.12, 13\u003Cbr>Cancer is one of the most important risk factors for human mortality in modern society. According to Global Cancer Observatory, about 9.7 million people died of cancer worldwide in 2022.4 Gynecological cancers, including ovarian, cervical, endometrial, vulvar, and fallopian tube cancers, are the leading causes of death in women.14 For now, the major therapies for gynecological cancers are still surgery and chemotherapy.15–17 However, the recurrence, metastasis, chemoresistance, and the still-growing global burden of gynecological cancers highligh","cbCaifIFgUjJtrqc","https://ap.wps.com/l/cbCaifIFgUjJtrqc","pdf",3782077,22,"English","# Introduction\n## The Mechanism of PNPs in Cancer Diagnosis and Treatment\n## Cargoes Loaded","[{\"question\":\"Why are polymer nanoparticles increasingly important for gynecological cancer research?\",\"answer\":\"They offer superior targeting ability and delivery efficiency, supporting both diagnosis and treatment. Their drug-loading flexibility and biocompatibility also make them promising therapeutic carriers.\"},{\"question\":\"What topics does the review cover about polymer nanoparticles in gynecological cancers?\",\"answer\":\"It covers polymer nanoparticle roles in tumor diagnosis and treatment, including drug delivery, imaging, combination therapy, and theranostic integration. It also summarizes polymer composition, principles, characteristics, and diverse therapeutic applications such as chemotherapy and immunotherapy.\"},{\"question\":\"What challenges remain before polymer nanoparticles can be widely used clinically?\",\"answer\":\"Clinical translation is limited by biosafety, heterogeneity of clinical effects, targeted delivery efficiency, and scale-up production. Very few nanoparticle systems have succeeded in moving into routine practice.\"}]","Polymer Nanoparticles Advancements for Gynecological Cancers | PDF",1790177309,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13df89683a8d8227869be449af8d85e1.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd4f77d99218b09660fa772cff2d8919.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd30e7bee6917dd49e9a4aa23ea3a921.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84d4f25ead1c4f99d95c33007f0116d5.webp",980,1268]